Einat Brill Almon
2012
In 2012, Einat Brill Almon earned a total compensation of $1.4M as Senior Vice President, Product Development at Protalix BioTherapeutics, a 291% increase compared to previous year.
Compensation breakdown
| Bonus | $215,000 |
|---|---|
| Option Awards | $547,846 |
| Salary | $244,716 |
| Stock Awards | $361,048 |
| Other | $67,763 |
| Total | $1,436,373 |
Almon received $547.8K in option awards, accounting for 38% of the total pay in 2012.
Almon also received $215K in bonus, $244.7K in salary, $361K in stock awards and $67.8K in other compensation.
Rankings
In 2012, Einat Brill Almon's compensation ranked 4,722nd out of 11,487 executives tracked by ExecPay. In other words, Almon earned more than 58.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,722 out of 11,487 | 59th |
Division Manufacturing | 1,645 out of 4,253 | 61st |
Major group Chemicals And Allied Products | 381 out of 1,203 | 68th |
Industry group Drugs | 239 out of 925 | 74th |
Industry Biological Products, Except Diagnostic Substances | 41 out of 165 | 75th |
Source: SEC filing on October 9, 2014.
Almon's colleagues
We found four more compensation records of executives who worked with Einat Brill Almon at Protalix BioTherapeutics in 2012.
2012
David Aviezer
Protalix BioTherapeutics
Chief Executive Officer
2012
Yoseph Shaaltiel
Protalix BioTherapeutics
Executive Vice President, Research and Development
2012
Yossi Maimon
Protalix BioTherapeutics
Chief Financial Officer
2012
Tzvi Palash
Protalix BioTherapeutics